Overview
Polidocanol Sclerotherapy of Pharynges for Obstructive Sleep Apnea (OSA) and Snoring Subjects(SS)
Status:
Unknown status
Unknown status
Trial end date:
2009-06-01
2009-06-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The aim of this prospective study is to evaluate the results of polidocanol sclerotherapy of pharynx for OSAS & SS,to reduce pharyngeal compliance.Phase:
Phase 1/Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Liaoyang Central HospitalTreatments:
Polidocanol
Criteria
Inclusion Criteria:- OSAS & SS which palatopharyngeal collapse.
Exclusion Criteria:
- obstructive sleep apnea syndrome (osas) & snoring subjects (ss),which anatomic narrow
result in.